These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8791029

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The clinical effectiveness of 311C90 in the acute treatment of migraine.
    Ferrari MD.
    Eur Neurol; 1996; 36 Suppl 2():4-7. PubMed ID: 8791025
    [Abstract] [Full Text] [Related]

  • 7. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.
    Ferrari MD.
    Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266
    [Abstract] [Full Text] [Related]

  • 8. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB, Stewart WF.
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical safety of 311C90: aggregated data from patients and volunteers to date.
    Earl NL.
    Eur Neurol; 1996 Oct; 36 Suppl 2():8-12. PubMed ID: 8791026
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy.
    Schoenen J, Sawyer J.
    Cephalalgia; 1997 Oct; 17 Suppl 18():28-40. PubMed ID: 9399015
    [Abstract] [Full Text] [Related]

  • 14. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD.
    Eur Neurol; 1996 Oct; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract] [Full Text] [Related]

  • 15. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
    Rapoport AM, Ramadan NM, Adelman JU, Mathew NT, Elkind AH, Kudrow DB, Earl NL.
    Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
    Mauskop A, Farkkila M, Hering-Hanit R, Rapoport A, Warner J.
    Curr Med Res Opin; 1999 Nov; 15(4):282-9. PubMed ID: 10640260
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.